Alkermes (ALKS) Interest Expenses (2010 - 2026)
Alkermes (ALKS) reported Interest Expenses of $20.9 million for Q1 2026, up 70.17% quarter-over-quarter from $12.3 million in Q4 2025.
Alkermes (ALKS) Interest Expenses (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 17 years of Interest Expenses data on file, last reported at $20.9 million in Q1 2026.
- Interest Expenses for Q1 2026 came in at $20.9 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $33.2 million (up 99.81% YoY), and the FY2025 annual result was $12.3 million, down 45.62% from the prior year.
- Interest Expenses climbed to $20.9 million in Q1 2026 per ALKS's latest filing, from $12.3 million in the prior quarter.
- Over five years, Interest Expenses peaked at $20.9 million in Q1 2026 and troughed at $2.4 million in Q1 2022.
- A 5-year average of $6.6 million and a median of $5.8 million in 2023 frame the typical range for Interest Expenses.
- The sharpest annual moves came in 2022 and 2025: Interest Expenses tumbled 40.81% in 2022, then soared 164.14% in 2025.
- A 5-year view of Interest Expenses shows it stood at $4.8 million in 2022, then gained by 26.94% to $6.1 million in 2023, then slipped by 23.22% to $4.6 million in 2024, then jumped by 164.14% to $12.3 million in 2025, then surged by 70.17% to $20.9 million in 2026.
- Business Quant data shows ALKS's Interest Expenses at $20.9 million in Q1 2026, $12.3 million in Q4 2025, and $4.6 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | - |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 62.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 3.00 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 20.89 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 4.86 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 6.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.89 Mn |
| Mar 31, 2026 | 20.89 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Dec 31, 2025 | 12.28 Mn |
| Dec 31, 2024 | 4.65 Mn |
| Dec 31, 2024 | 4.65 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Sep 30, 2024 | 6.00 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Jun 30, 2024 | 5.95 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Mar 31, 2024 | 5.98 Mn |
| Dec 31, 2023 | 6.05 Mn |
| Dec 31, 2023 | 6.05 Mn |
| Sep 30, 2023 | 6.01 Mn |
| Sep 30, 2023 | 6.01 Mn |
| Jun 30, 2023 | 5.68 Mn |
| Jun 30, 2023 | 5.68 Mn |
| Mar 31, 2023 | 5.29 Mn |
| Mar 31, 2023 | 5.29 Mn |